Yun Weijing, Qian Lei, Yuan Ruqiang, Xu Hu
Advanced Institute for Medical Sciences, Dalian Medical University, Dalian, China.
Front Cardiovasc Med. 2021 Nov 19;8:732554. doi: 10.3389/fcvm.2021.732554. eCollection 2021.
Doxorubicin-driven cardiotoxicity could result in dilated cardiomyopathy and heart failure (HF). Previously, we showed that periplocymarin exerted a cardiotonic role by promoting calcium influx and attenuating myocardial fibrosis induced by isoproterenol (ISO) by improving the metabolism of cardiomyocytes. However, the impact of periplocymarin on doxorubicin (DOX)-triggered cardiomyopathy has not been investigated. In the current study, C57BL/6 mice were randomly divided into three groups, namely, the control, DOX, and DOX+periplocymarin groups. The cardiac function and apoptosis were measured. Our results revealed that periplocymarin administration greatly improved the DOX-induced cardiac dysfunction manifested by the ejection fraction (EF%), fractional shortening (FS%), left ventricular posterior wall thickness (LVPW), left ventricular anterior wall thickness (LVAW), left ventricular (LV) mass, and attenuated DOX-induced cardiomyocyte apoptosis assessed by hematoxylin and eosin (H&E) staining, terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining, and western blotting. Further study using H9c2 cells revealed that the pretreatment of periplocymarin suppressed DOX-induced apoptosis evidenced by annexin V staining. Moreover, liquid chromatography with tandem mass spectrometry (LC-MS/MS) analysis demonstrated that DOX lead to an accumulation in serum ceramide, and the pre-treatment of periplocymarin could reverse this phenomenon. Network pharmacology also demonstrated that ceramide metabolism was involved in the process. Consistently, real-time PCR showed that periplocymarin significantly abolished the induction of the genes involved in the synthesis of ceramide, i.e., , and , and the induction was attributed to the treatment of DOX. Collectively, these results suggested that periplocymarin reduced cardiomyocyte apoptosis to protect hearts from DOX-induced cardiotoxicity and the synthesis of ceramides was involved in this process.
阿霉素引发的心脏毒性可导致扩张型心肌病和心力衰竭(HF)。此前,我们发现杠柳毒苷通过促进钙内流以及改善心肌细胞代谢来减轻异丙肾上腺素(ISO)诱导的心肌纤维化,从而发挥强心作用。然而,杠柳毒苷对阿霉素(DOX)引发的心肌病的影响尚未得到研究。在本研究中,C57BL/6小鼠被随机分为三组,即对照组、DOX组和DOX + 杠柳毒苷组。测量了心脏功能和细胞凋亡情况。我们的结果显示,给予杠柳毒苷极大地改善了DOX诱导的心脏功能障碍,表现为射血分数(EF%)、缩短分数(FS%)、左心室后壁厚度(LVPW)、左心室前壁厚度(LVAW)、左心室(LV)质量,并且通过苏木精和伊红(H&E)染色、末端脱氧核苷酸转移酶dUTP缺口末端标记(TUNEL)染色和蛋白质印迹法评估发现,杠柳毒苷减轻了DOX诱导的心肌细胞凋亡。使用H9c2细胞的进一步研究表明,杠柳毒苷预处理可抑制DOX诱导的凋亡,这通过膜联蛋白V染色得以证明。此外,液相色谱 - 串联质谱(LC-MS/MS)分析表明,DOX导致血清神经酰胺积累,而杠柳毒苷预处理可逆转这一现象。网络药理学也表明神经酰胺代谢参与了这一过程。同样,实时PCR显示杠柳毒苷显著消除了DOX处理所诱导的参与神经酰胺合成的基因,即 、 和 的表达。总体而言,这些结果表明杠柳毒苷减少心肌细胞凋亡以保护心脏免受DOX诱导的心脏毒性,并且神经酰胺的合成参与了这一过程。